ESR1 and breast carcinoma: In this study, the induction of estrogen receptor 1 (ESR1) mRNA and ER protein downregulation, through a mitogen- activated protein kinase (MAPK)-independent mechanism, was achieved by the treatment of breast cancer cells with conditioned culture media from either cancer-activated BM stromal cells or HS5 BM stromal cell line.